The 3rd Precision Medicine in Inflammatory Bowel Disease Summit provides an unmatched opportunity to connect with senior decision-makers from the immunology, gastrointestinal, and precision medicine sectors, committed to advancing innovation and overcoming challenges in this dynamic field.
Our audience of 80+ senior key opinion leaders are actively pursuing partnerships in data management, AI/ML, technological innovation, multi-omics sequencing and analysis, biomarker development, and other cutting-edge services. They are eager to connect and collaborate with leading solution and service providers driving advancements in these fields.
Our Audience are Looking for:
Who Will You Meet?
AI / Bioinformatics / Computation Providers: Tools to analyze complex datasets, enhance patient stratification, and optimize precision medicine approaches
Diagnostics: Advanced technologies to drive biomarker development, improve disease monitoring, and enable targeted therapies
Omics: Multi-omics insights to uncover novel therapeutic targets and refine personalized treatment pathways
CROs: Expertise to streamline clinical trials, ensure regulatory compliance, and accelerate drug development
Why Partner?
Showcase Your Innovative Technologies & Diagnostic Services to a Targeted Audience of Senior Leaders in Precision Medicine for IBD
Showcase your cutting-edge technologies and diagnostic services to an audience of senior leaders driving unprecedented innovation in precision medicine for IBD. With agenda topics ranging from AI-driven patient stratification to multi-omics analysis, combination therapies, and advanced imaging tools, align your solutions with the most pressing challenges in IBD care. Leverage strategic exposure before, during, and after the summit to demonstrate your impact, foster meaningful partnerships, and solidify your position as a leader transforming outcomes for patients with inflammatory bowel disease.
Gain Strategic Market Insights to Stay Ahead in the Dynamic IBD Landscape
Stay ahead in the rapidly evolving precision medicine landscape for IBD. Understand the key priorities of biopharma and precision medicine leaders seeking innovative tools to improve patient stratification, disease monitoring, and therapeutic outcomes. Position your solutions to meet the latest regulatory requirements and scientific advancements, ensuring you remain a critical partner in advancing care for patients with inflammatory bowel disease.
Forge High-Impact Collaborations with Influential Stakeholders from Biopharma, Diagnostics, & Academic Institutions
Participate in dedicated networking opportunities, including speed networking and targeted discussions, to build valuable partnerships that drive progress in IBD diagnostics and patient care. Collaborate with leaders sharing a common goal of advancing precision medicine and improving outcomes for patients with inflammatory bowel disease.
